drugset / Trial / NCT00835172
Glimepiride 4 mg Tablets Under Non-Fasting Conditions
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study is to compare the relative bioavailability of glimepiride 4 mg tablets (manufactured by TEVA Pharmaceutical Industries, Ltd. and distributed by TEVA Pharmaceuticals USA) with that of AMARYL® tablets (Aventis) in healthy, adult, non-smoking subjects under non-fasting conditions.
Timeline
- Start
- 2003-03
- Primary completion
- 2003-03
- Completion
- 2003-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glimepiride | Small molecule | 4 mg | — |
Indications
No indication recorded.